• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pragmatic Opioid Use in Painful Diabetic Neuropathy.实用的阿片类药物在疼痛性糖尿病神经病变中的应用
Eur Endocrinol. 2020 Apr;16(1):21-24. doi: 10.17925/EE.2020.16.1.21. Epub 2020 Feb 4.
2
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.慢性非癌性疼痛阿片类药物的合理、安全与有效处方:美国介入性疼痛医师协会(ASIPP)指南
Pain Physician. 2017 Feb;20(2S):S3-S92.
3
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.美国介入性疼痛医师学会(ASIPP)慢性非癌痛患者阿片类药物负责任处方指南:第 2 部分——指南。
Pain Physician. 2012 Jul;15(3 Suppl):S67-116.
4
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
5
Risk Assessment and Monitoring of Patients with Cancer Receiving Opioid Therapy.癌症患者接受阿片类药物治疗的风险评估和监测。
Oncologist. 2019 Oct;24(10):1294-1298. doi: 10.1634/theoncologist.2019-0301. Epub 2019 May 22.
6
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).慢性疼痛中的处方阿片类药物滥用:阿片类药物滥用预测因素及遏制阿片类药物滥用策略的最新综述(第2部分)
Pain Physician. 2017 Feb;20(2S):S111-S133.
7
Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.处方阿片类药物的误用、滥用、发病率和死亡率:平衡有效的疼痛管理与安全性
Pain Med. 2015 Oct;16 Suppl 1:S3-8. doi: 10.1111/pme.12904. Epub 2015 Sep 11.
8
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.慢性疼痛中的处方阿片类药物滥用:阿片类药物滥用预测因素及遏制阿片类药物滥用策略的最新综述:第1部分
Pain Physician. 2017 Feb;20(2S):S93-S109.
9
10
Opioids Use and Abuse: Prescription Practice, Attitude, and Beliefs among Doctors of Karachi.卡拉奇医生的阿片类药物使用与滥用:处方行为、态度及信念
Cureus. 2019 Jul 27;11(7):e5253. doi: 10.7759/cureus.5253.

引用本文的文献

1
Diabetic neuropathy: cutting-edge research and future directions.糖尿病神经病变:前沿研究与未来方向
Signal Transduct Target Ther. 2025 Apr 25;10(1):132. doi: 10.1038/s41392-025-02175-1.
2
Astaxanthin has a beneficial influence on pain-related symptoms and opioid-induced hyperalgesia in mice with diabetic neuropathy-evidence from behavioral studies.虾青素对糖尿病神经病变小鼠疼痛相关症状和阿片类药物引起的痛觉过敏有有益影响——来自行为研究的证据。
Pharmacol Rep. 2024 Dec;76(6):1346-1362. doi: 10.1007/s43440-024-00671-9. Epub 2024 Nov 12.
3
The efficacy and safety of epidural morphine/hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study.硬膜外注射吗啡/氢吗啡酮治疗顽固性带状疱疹后神经痛的疗效与安全性:一项单中心、双盲、随机对照、前瞻性非劣效性研究。
Front Pharmacol. 2022 Dec 6;13:1051357. doi: 10.3389/fphar.2022.1051357. eCollection 2022.
4
Healthcare Economics of High Frequency Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy.高频脊髓刺激治疗糖尿病性周围神经痛的医疗经济学
J Diabetes Sci Technol. 2024 May;18(3):635-643. doi: 10.1177/19322968221128321. Epub 2022 Oct 31.
5
First-in-Human Single-Ascending-Dose, Multiple-Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy.用于治疗糖尿病周围神经痛的新型非阿片类药物 NRD.E1 的首次人体单剂量、多剂量和食物相互作用研究。
Clin Pharmacol Drug Dev. 2022 Sep;11(9):1012-1027. doi: 10.1002/cpdd.1103. Epub 2022 Jun 14.
6
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.糖尿病感觉运动性周围神经病变的发病机制、诊断和临床管理。
Nat Rev Endocrinol. 2021 Jul;17(7):400-420. doi: 10.1038/s41574-021-00496-z. Epub 2021 May 28.
7
Predicting the quality of life based on pain dimensions and psychiatric symptoms in patients with Painful diabetic neuropathy: a cross-sectional prevalence study in Iranian patients.基于疼痛维度和精神症状预测疼痛性糖尿病周围神经病变患者的生活质量:伊朗患者的横断面患病率研究。
Health Qual Life Outcomes. 2021 Feb 9;19(1):49. doi: 10.1186/s12955-021-01697-w.

本文引用的文献

1
Why patients are afraid of opioid analgesics: a study on opioid perception in patients with chronic pain.为什么患者害怕阿片类镇痛药:慢性疼痛患者对阿片类药物感知的研究。
Pol Arch Intern Med. 2018 Feb 28;128(2):89-97. doi: 10.20452/pamw.4167. Epub 2017 Dec 14.
2
Morphine for chronic neuropathic pain in adults.吗啡用于成人慢性神经性疼痛。
Cochrane Database Syst Rev. 2017 May 22;5(5):CD011669. doi: 10.1002/14651858.CD011669.pub2.
3
Methadone for neuropathic pain in adults.美沙酮用于成人神经性疼痛
Cochrane Database Syst Rev. 2017 May 17;5(5):CD012499. doi: 10.1002/14651858.CD012499.pub2.
4
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.慢性非癌性疼痛阿片类药物的合理、安全与有效处方:美国介入性疼痛医师协会(ASIPP)指南
Pain Physician. 2017 Feb;20(2S):S3-S92.
5
Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain.经皮丁丙诺啡缓解神经病理性疼痛:糖尿病周围神经病理性疼痛的随机、双盲、平行分组、安慰剂对照试验。
Diabetes Care. 2016 Sep;39(9):1493-500. doi: 10.2337/dc16-0123. Epub 2016 Jun 16.
6
Perceptions of patient provider agreements.对医患协议的认知。
J Pharm Health Serv Res. 2015 Sep;6(3):139-144. doi: 10.1111/jphs.12099. Epub 2015 Jun 16.
7
Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.处方药监测项目与医生持续减少阿片类药物处方量有关。
Health Aff (Millwood). 2016 Jun 1;35(6):1045-51. doi: 10.1377/hlthaff.2015.1673.
8
Seizures associated with low-dose tramadol for chronic pain treatment.与低剂量曲马多用于慢性疼痛治疗相关的癫痫发作。
Anesth Essays Res. 2016 May-Aug;10(2):376-8. doi: 10.4103/0259-1162.177181.
9
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
10
Opioid use in the management of diabetic peripheral neuropathy (DPN) in a large commercially insured population.在一个大型商业保险人群中阿片类药物用于糖尿病周围神经病变(DPN)的管理。
Clin J Pain. 2015 May;31(5):414-24. doi: 10.1097/AJP.0000000000000124.

实用的阿片类药物在疼痛性糖尿病神经病变中的应用

Pragmatic Opioid Use in Painful Diabetic Neuropathy.

作者信息

Balhara Yatan Pal Singh, Singh Shalini, Kalra Sanjay

机构信息

Department of Psychiatry, National Drug Dependence Treatment Center, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Institute of Liver and Biliary Sciences (ILBS), New Delhi, India.

出版信息

Eur Endocrinol. 2020 Apr;16(1):21-24. doi: 10.17925/EE.2020.16.1.21. Epub 2020 Feb 4.

DOI:10.17925/EE.2020.16.1.21
PMID:32595765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7308105/
Abstract

The management of painful diabetic neuropathy poses a tough clinical challenge. Although opioid analgesics are considered as second- or third-line agents in the management of moderate-to-severe neuropathic pain, prescription of opioids for this indication is higher than expected. This narrative review is a recommendation on how to ensure pragmatic use of opioids for those with painful diabetic neuropathy while avoiding complications such as opioid overdose, opioid diversion and the development of opioid-use disorder. Risk mitigation strategies at the level of the clinician include periodic assessment and documentation of clinical details, treatment history and psychosocial status. Using a multimodal approach to pain management, medication counselling, adherence monitoring programmes, evidence-based opioid dosing strategies and empowering patients to make treatment decisions are effective strategies in reducing risk associated with prolonged opioid use. At the organisational and policy level, using prescription drug monitoring programmes, carrying out periodic opioid utilisation reviews and providing training to patients and physicians on safe opioid use are useful, implementable strategies.

摘要

疼痛性糖尿病神经病变的管理是一项严峻的临床挑战。尽管阿片类镇痛药在中重度神经病理性疼痛的管理中被视为二线或三线药物,但针对这一适应症开具阿片类药物的处方量高于预期。这篇叙述性综述是关于如何确保对疼痛性糖尿病神经病变患者切实合理使用阿片类药物,同时避免诸如阿片类药物过量、阿片类药物转移以及阿片类药物使用障碍等并发症的建议。临床医生层面的风险缓解策略包括定期评估和记录临床细节、治疗史及社会心理状况。采用多模式疼痛管理方法、药物咨询、依从性监测计划、基于证据的阿片类药物给药策略以及让患者参与治疗决策,都是降低与长期使用阿片类药物相关风险的有效策略。在组织和政策层面,利用处方药监测计划、定期开展阿片类药物使用审查以及为患者和医生提供安全使用阿片类药物的培训,都是有用且可实施的策略。